Tower Research Capital (TRC)’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,827
Closed -$3.28K 5248
2024
Q4
$3.28K Buy
7,827
+3,303
+73% +$1.38K ﹤0.01% 4677
2024
Q3
$4.44K Sell
4,524
-11,563
-72% -$11.4K ﹤0.01% 4539
2024
Q2
$24.5K Buy
16,087
+5,800
+56% +$8.82K ﹤0.01% 3643
2024
Q1
$23.4K Buy
10,287
+5,670
+123% +$12.9K ﹤0.01% 2864
2023
Q4
$13.5K Sell
4,617
-6,365
-58% -$18.7K ﹤0.01% 3955
2023
Q3
$46.5K Buy
10,982
+9,252
+535% +$39.1K ﹤0.01% 2610
2023
Q2
$15.2K Buy
1,730
+1,389
+407% +$12.2K ﹤0.01% 3621
2023
Q1
$1K Buy
341
+134
+65% +$393 ﹤0.01% 5506
2022
Q4
$3K Sell
207
-174
-46% -$2.52K ﹤0.01% 5157
2022
Q3
$3K Sell
381
-208
-35% -$1.64K ﹤0.01% 5371
2022
Q2
$10K Sell
589
-314
-35% -$5.33K ﹤0.01% 4433
2022
Q1
$11K Buy
903
+242
+37% +$2.95K ﹤0.01% 4149
2021
Q4
$11K Buy
661
+18
+3% +$300 ﹤0.01% 4391
2021
Q3
$10K Buy
643
+330
+105% +$5.13K ﹤0.01% 4304
2021
Q2
$29K Sell
313
-1,181
-79% -$109K ﹤0.01% 3515
2021
Q1
$78K Buy
1,494
+903
+153% +$47.1K ﹤0.01% 2777
2020
Q4
$16K Sell
591
-499
-46% -$13.5K ﹤0.01% 3999
2020
Q3
$31K Sell
1,090
-790
-42% -$22.5K ﹤0.01% 3713
2020
Q2
$27K Buy
1,880
+1,441
+328% +$20.7K ﹤0.01% 3503
2020
Q1
$5K Buy
439
+279
+174% +$3.18K ﹤0.01% 2282
2019
Q4
$3K Sell
160
-13
-8% -$244 ﹤0.01% 2880
2019
Q3
$4K Sell
173
-29
-14% -$671 ﹤0.01% 3392
2019
Q2
$7K Buy
+202
New +$7K ﹤0.01% 2751
2019
Q1
Sell
-13
Closed 3812
2018
Q4
$0 Buy
+13
New ﹤0.01% 3844
2016
Q1
Sell
-22
Closed -$1K 4160
2015
Q4
$1K Buy
+22
New +$1K ﹤0.01% 4030
2015
Q2
Sell
-141
Closed -$25K 4423
2015
Q1
$25K Buy
+141
New +$25K ﹤0.01% 2061
2014
Q4
Sell
-496
Closed -$111K 4057
2014
Q3
$111K Buy
496
+453
+1,053% +$101K 0.01% 838
2014
Q2
$11K Buy
+43
New +$11K ﹤0.01% 2262